Rsid Chr Position P value Ref Alt Gwas trait Gene symbol Variant type PMID
rs7519514 chr1 161739190 0.0000000306 A G White blood cell count ATF6 intron 21738479
rs7519514 chr1 161739190 0.00000637 A G Type 2 diabetes ATF6 intron 22158537
rs905594 chr1 161741274 0.0000000532 T C White blood cell count ATF6 intron 21738479
rs905594 chr1 161741274 0.0000352 T C Type 2 diabetes ATF6 intron 22158537
rs905594 chr1 161741274 0.00000381 T C Diabetes Mellitus ATF6 intron pha003059
rs1027700 chr1 161757036 0.000000115 A T Type 2 diabetes ATF6 intron 22158537
rs6698956 chr1 161758744 0.0004616 T C Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) ATF6 intron 23233654
rs6698956 chr1 161758744 0.000462 T C Methotrexate clearance (acute lymphoblastic leukemia) ATF6 intron 23233662
rs11576878 chr1 161775577 0.000000206 A G Type 2 diabetes ATF6 intron 22158537
rs2134697 chr1 161780979 0.0000102 G A Type 2 diabetes ATF6 intron 22158537
rs16849542 chr1 161786495 1.77e-25 A G Narcolepsy ATF6 intron 19629137
rs11581556 chr1 161793612 0.000000859 G A Type 2 diabetes ATF6 intron 22158537
rs10918029 chr1 161795896 0.0004025 G A Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) ATF6 intron 23233654
rs10918029 chr1 161795896 0.000403 G A Methotrexate clearance (acute lymphoblastic leukemia) ATF6 intron 23233662
rs12691498 chr1 161809706 0.000373 T A Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) ATF6 intron 23233654
rs12691498 chr1 161809706 0.000373 T A Methotrexate clearance (acute lymphoblastic leukemia) ATF6 intron 23233662
rs1006310 chr1 161811555 0.000000261 T C White blood cell count ATF6 intron 21738479
rs1006310 chr1 161811555 0.000586 T C Type 2 diabetes ATF6 intron 22158537
rs3767635 chr1 161820904 0.000018 A G Urinary metabolites ATF6 intron 21572414
rs931778 chr1 161823618 0.000000198 A G White blood cell count ATF6 intron 21738479
rs931778 chr1 161823618 0.000873 A G Type 2 diabetes ATF6 intron 22158537
rs3767633 chr1 161826615 0.000008 T A IgG glycosylation ATF6 intron 23382691
rs2340721 chr1 161849385 0.000000346 A C White blood cell count ATF6 intron 21738479
rs2340721 chr1 161849385 0.000796 A C Type 2 diabetes ATF6 intron 22158537
rs10918137 chr1 161862555 0.000000336 G A White blood cell count ATF6 intron 21738479
rs12124509 chr1 161867489 0.000000114 G A White blood cell count ATF6 intron 21738479
rs2341475 chr1 161878608 0.0000885 A G Type 2 diabetes ATF6 intron 22158537
rs12079579 chr1 161880482 0.00056 G A Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) ATF6 intron 23233654
rs12079579 chr1 161880482 0.00056 G A Methotrexate clearance (acute lymphoblastic leukemia) ATF6 intron 23233662
rs4657121 chr1 161883083 0.00000079 G A Type 2 diabetes ATF6 intron 22158537
rs4657121 chr1 161883083 0.0000449 G A Neuroblastoma ATF6 intron pha002895
rs7554023 chr1 161896364 0.00001 A G Lung function (forced expiratory flow between 25% and 75% of forced vital capacity) ATF6 intron 24023788
rs10918270 chr1 161915501 0.000008 G A Parkinson's disease (age of onset) ATF6 intron 19772629
rs3795649 chr1 161931562 0.0000969 G A Heart Failure ATF6 UTR-3 pha002885